This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike
by Zacks Equity Research
Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
6 Defensive Stocks to Combat Market Turbulence
by Swarup Gupta
With the trade war likely to weigh on the global economy, defensive stocks are a prudent choice for investors.
Flowers Foods (FLO) Stock Rises on Q1 Earnings & Sales Beat
by Zacks Equity Research
Flowers Foods (FLO) Q1 results gain on solid pricing, improvements at DKB, Nature's Own and Wonder brands and contributions from Canyon Bakehouse.
General Mills (GIS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
General Mills (GIS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Boston Beer Fortifies Craft Footprint with Dogfish Head Merger
by Zacks Equity Research
Boston Beer (SAM) enters into a merger agreement with Dogfish Head Brewery in a cash and stock deal worth about $300 million.
Top Ranked Growth Stocks to Buy for May 9th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 9th.
Medifast (MED) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 11.84% and 9.35%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Medifast's (MED) Q1 Earnings to Gain From OPTAVIA Brands
by Zacks Equity Research
Sturdy growth in the OPTAVIA banner is likely to boost Medifast's (MED) Q1 results. However, rising freight and SG&A expenses are concerns.
Helen of Troy (HELE) Q4 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Helen of Troy's (HELE) Q4 performance benefits from improved margins as well as strength in the Housewares businesses. However, sluggish Health & Home unit disappoints.
Archer Daniels (ADM) Q1 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports dismal first-quarter 2019 earnings due to adverse winter weather conditions in North America, which hurt the company's operations.
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Top Ranked Growth Stocks to Buy for April 26th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 26th.
Buyouts & Lower Costs Drive Hershey's (HSY) Q1 Earnings
by Zacks Equity Research
Hershey's (HSY) Q1 earnings and sales increase year over year and also beat the Zacks Consensus Estimate.
Altria's (MO) Q1 Earnings Miss Estimates, High Interests Hurt
by Zacks Equity Research
Altria's (MO) Q1 performance hurt by high interest expenses as well as lower revenues in the smokeable segment.
Medifast (MED) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Logitech International and Molina Healthcare
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Logitech International and Molina Healthcare
Top Ranked Growth Stocks to Buy for April 24th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 24th.
Procter & Gamble (PG) Q3 Earnings & Sales Beat Estimates
by Zacks Equity Research
Procter & Gamble (PG) posts robust third-quarter fiscal 2019 results. Also, it raises sales forecast for fiscal 2019.
Bet on These 4 Liquid Stocks for a Successful Portfolio
by Zacks Equity Research
Four top-ranked liquid stocks that can make up a winning portfolio for investors.
Mondelez (MDLZ) to Boost Snacks Unit, Invests in Hu Master
by Zacks Equity Research
Mondelez International (MDLZ) focuses on partnerships to boost snacking business.
Philip Morris (PM) Q1 Earnings Top Estimates, Revenues Down
by Zacks Equity Research
Philip Morris' (PM) Q1 results benefit from pricing and improved results from the RRPs category. However, the combustible unit continues to be weak.
Will Avon's Open Up Strategy Aid Representative Growth?
by Zacks Equity Research
Avon (AVP) struggles with soft Representatives growth, which is hurting its top-line performance. However, the company's 'Open Up Avon' strategy appears promising.
Hormel Foods Refines Portfolio, Completes CytoSport Sale
by Zacks Equity Research
Post the sale of CytoSport, the Evolve and Muscle Milk brands are no longer part of Hormel Foods' (HRL) business.